Hydrocodone Bitartrate and Acetaminophen Oral Solution 7.5 mg/325 mg per 15 mL (Cherry Flavored),...
FDA Drug Recall #D-1139-2017 — Class III — August 17, 2017
Recall Summary
| Recall Number | D-1139-2017 |
| Classification | Class III — Low risk |
| Date Initiated | August 17, 2017 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | VistaPharm, Inc. |
| Location | Largo, FL |
| Product Type | Drugs |
| Quantity | 3084 bottles |
Product Description
Hydrocodone Bitartrate and Acetaminophen Oral Solution 7.5 mg/325 mg per 15 mL (Cherry Flavored), 473 mL bottles, Rx only, Manufactured by: VistaPharm, Inc. Largo, FL 33771 ---- NDC 66689-023-16
Reason for Recall
Labeling: Not Elsewhere Classified; product is incorrectly labeled as Class III controlled substance instead of Class II controlled substance
Distribution Pattern
Nationwide
Lot / Code Information
Lot: 494700 Exp. 10/2018
Other Recalls from VistaPharm, Inc.
| Recall # | Classification | Product | Date |
|---|---|---|---|
| D-0018-2023 | Class II | Pyridostigmine Bromide Oral Solution, USP 60 mg... | Sep 30, 2022 |
| D-0376-2022 | Class II | Clobazam Oral Suspension 2.5 mg/mL, 120 mL bott... | Jan 7, 2022 |
| D-0019-2021 | Class III | NYSTATIN ORAL SUSPENSION, USP 100,000 units per... | Sep 25, 2020 |
| D-1378-2020 | Class III | Nystatin Oral Suspension, USP 100,000 units per... | Jun 23, 2020 |
| D-1377-2020 | Class III | Nystatin Oral Suspension, USP 500,000 units/5mL... | Jun 23, 2020 |
Frequently Asked Questions
Stop using the medication immediately and contact your pharmacist. A mislabeling recall can range from a minor technical error (wrong font size) to a serious mix-up where one drug is inside another drug's packaging. If you received a medication that looks or acts differently than expected, or if you experienced unexpected effects, tell your doctor immediately. The pharmacist can verify whether your specific lot is affected and provide a replacement. Report any adverse effects experienced to FDA MedWatch at 1-800-FDA-1088.
Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.
Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.
What Should You Do?
Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.